Results of a Phase I trial of OMP-54F28 , an investigational drug candidate targeting cancer stem cells have been released.
http://ift.tt/1nGydDm
http://ift.tt/1nGydDm
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment